Production (Stage)
Entrada Therapeutics, Inc.
TRDA
$7.59
-$0.26-3.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.92% | -6.53% | -4.34% | 43.47% | -6.98% |
| Total Receivables | -17.08% | 44.10% | -58.09% | -88.44% | 936.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.93% | 16.19% | 13.74% | 29.99% | -19.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.37% | -5.44% | -4.94% | 18.20% | 12.01% |
|
|
|||||
| Total Current Assets | -8.37% | -5.44% | -4.94% | 18.20% | 12.01% |
| Net Property, Plant & Equipment | -3.60% | -2.97% | -3.61% | -2.48% | -2.94% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.06% | -9.84% | -0.02% | -30.02% | -0.42% |
| Total Assets | -7.57% | -5.10% | -4.70% | 13.92% | 8.88% |
|
|
|||||
| Total Accounts Payable | -48.63% | 229.64% | -20.98% | -35.30% | -22.89% |
| Total Accrued Expenses | -45.55% | -1.00% | 23.06% | 25.44% | -21.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -13.88% | -2.31% | -9.68% | 3.20% | 4.96% |
| Total Finance Division Other Current Liabilities | -80.25% | -68.75% | -24.98% | -57.75% | 12.94% |
| Total Other Current Liabilities | -80.25% | -68.75% | -24.98% | -57.75% | 12.94% |
| Total Current Liabilities | -53.32% | -44.08% | -17.72% | -50.67% | 9.54% |
|
|
|||||
| Total Current Liabilities | -53.32% | -44.08% | -17.72% | -50.67% | 9.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.25% | -3.60% | -4.12% | -3.88% | -3.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -95.38% | -18.22% | -23.08% | 10.04% | 21.94% |
| Total Liabilities | -29.11% | -26.11% | -13.09% | -37.04% | 6.46% |
|
|
|||||
| Common Stock & APIC | 0.98% | 1.11% | 0.96% | 23.94% | 0.90% |
| Retained Earnings | -13.41% | 0.87% | -12.05% | 32.09% | 12.05% |
| Treasury Stock & Other | 1,116.28% | -104.42% | 395.44% | -33.74% | -226.15% |
| Total Common Equity | -2.66% | 1.47% | -1.74% | 59.61% | 11.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.66% | 1.47% | -1.74% | 59.61% | 11.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.66% | 1.47% | -1.74% | 59.61% | 11.14% |
|
|
|||||